Inari Medical Inc (NAS:NARI)
$ 50.05 1.12 (2.29%) Market Cap: 2.93 Bil Enterprise Value: 2.79 Bil PE Ratio: 0 PB Ratio: 6.73 GF Score: 80/100

Q2 2020 Inari Medical Inc Earnings Call Transcript

Aug 11, 2020 / 08:30PM GMT
Release Date Price: $62.13 (-9.63%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Inari Medical, Inc. Second Quarter 2020 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Caroline Corner, Investor Relations. Please go ahead, ma'am.

Caroline V. Corner
Westwicke Partners, LLC - MD

Thank you, operator. Welcome to Inari's second quarter 2020 earnings call. Joining me on today's call are Bill Hoffman, President and Chief Executive Officer; and Mitch Hill, Chief Financial Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which Inari operates, trends and expectations for Inari's products and technology, trends and demand for Inari's products, Inari's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot